Erratum Regarding “Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report” (Am J Kidney Dis. 2017;70[6]:859-868)

In the Perspective entitled "Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report" that appeared in the December 2017 issue of AJKD (Bansal et al, volume 70, issue 6, pages 859-868), some corrections are needed to resolve ambiguities in the content related to warfarin alternatives.

http://bit.ly/2STKKZ1